State Street Corp trimmed its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 0.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,464,881 shares of the medical instruments supplier's stock after selling 55,623 shares during the period. State Street Corp owned about 3.25% of DENTSPLY SIRONA worth $175,967,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of XRAY. Raymond James Trust N.A. grew its stake in DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier's stock valued at $241,000 after purchasing an additional 453 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in DENTSPLY SIRONA by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock valued at $637,000 after acquiring an additional 560 shares during the last quarter. LRI Investments LLC grew its position in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 564 shares during the period. Diversified Trust Co increased its stake in shares of DENTSPLY SIRONA by 3.0% during the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier's stock worth $489,000 after purchasing an additional 566 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. Institutional investors own 95.70% of the company's stock.
DENTSPLY SIRONA Trading Down 1.7 %
Shares of NASDAQ XRAY traded down $0.35 during midday trading on Friday, reaching $19.66. The stock had a trading volume of 1,141,251 shares, compared to its average volume of 3,089,437. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The company's 50 day moving average price is $21.39 and its 200 day moving average price is $24.26. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same period in the previous year, the business earned $0.49 EPS. The firm's revenue was up .4% compared to the same quarter last year. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
DENTSPLY SIRONA Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.26%. DENTSPLY SIRONA's dividend payout ratio is currently -30.92%.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Finally, Leerink Partners lowered DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday, November 7th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and an average target price of $28.40.
Get Our Latest Research Report on XRAY
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.